You are here

cancer

TORL BioTherapeutics launches with $158M to target cancer

Labiotech.eu

Sun, 04/16/23 - 11:12 pm

TORL BioTherapeutics

Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment

BioPharma Dive

Thu, 04/13/23 - 10:04 am

Function Oncology

GSK outlines deal to send cell therapies back to Adaptimmune

BioPharma Dive

Tue, 04/11/23 - 11:41 am

Adaptimmune Therapeutics

Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine

Investors Business Daily

Mon, 04/10/23 - 04:51 pm

Moderna Therapeutics

Merck/Eisai Drops Melanoma Program for Keytruda-Lenvima Combo After Phase III Fail

BioSpace

Fri, 04/7/23 - 01:58 pm

clinical trials

colorectal cancer

AbbVie removes two approvals for blood cancer drug Imbruvica

BioPharma Dive

Fri, 04/7/23 - 01:49 pm

White House rolls out new cancer initiative to help implement ‘Moonshot’

The Hill

Wed, 04/5/23 - 10:19 am

cancer moonshot

BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal

Reuters

Mon, 04/3/23 - 09:46 am

drug development

BriaCell presses up new company with a couple of preclinical cancer meds

Fierce Biotech

Thu, 03/30/23 - 10:54 pm

Mathai Mammen, former J&J executive, to become FogPharma CEO

BioPharma Dive

Thu, 03/30/23 - 10:11 am

Monopar Drops Lead Candidate after Disappointing Phase III Analysis

BioSpace

Wed, 03/29/23 - 09:51 am

Monopar Therapeutics

clinical trials

severe oral mucositis

FDA lifts partial hold on Blueprint's CDK2 inhibitor

Endpoints

Wed, 03/29/23 - 09:43 am

Blueprint Medicines

AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning lead drug

Fierce Biotech

Tue, 03/28/23 - 10:22 am

CytomX Therapeutics

antibody-drug conjugate

Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients

Marketscreener

Tue, 03/28/23 - 10:20 am

Covant Therapeutics

Boehringer Ingelheim

In new PD-1 showdown, GSK's Jemperli loses initial edge on Merck's Keytruda

Fierce Pharma

Mon, 03/27/23 - 10:09 pm

Merck KGaA takes back control of PD-L1 cancer drug as Pfizer alliance ends

Endpoints

Mon, 03/27/23 - 10:04 pm

Proposed FDA guidelines to strengthen oversight on accelerated approval cancer drugs

Medical Marketing and Media

Mon, 03/27/23 - 09:57 pm

clinical trials

accelerated approvals

BioNTech signs deal to co-develop OncoC4's cancer drug

Reuters

Tue, 03/21/23 - 10:05 am

drug development

Keytruda Unlocked: How Should Merck Proceed with Trials?

BioSpace

Tue, 03/14/23 - 11:19 am

clinical trials

FDA pauses Mersana’s clinical trial after patient dies

Endpoints

Mon, 03/13/23 - 10:54 am

clinical trials

antibody-drug conjugate

Pages